Autocrine fibroblast growth factor 18 mediates dexamethasone‐induced osteogenic differentiation of murine mesenchymal stem cells

The potential of mesenchymal stem cells (MSC) to differentiate into functional bone forming cells provides an important tool for bone regeneration. The identification of factors capable of promoting osteoblast differentiation in MSCs is therefore critical to enhance the osteogenic potential of MSCs. Using microarray analysis combined with biochemical and molecular approach, we found that FGF18, a member of the FGF family, is upregulated during osteoblast differentiation induced by dexamethasone in murine MSCs. We showed that overexpression of FGF18 by lentiviral (LV) infection, or treatment of MSCs with recombinant human (rh)FGF18 increased the expression of the osteoblast specific transcription factor Runx2, and enhanced osteoblast phenotypic marker gene expression and in vitro osteogenesis. Molecular silencing using lentiviral shRNA demonstrated that downregulation of FGFR1 or FGFR2 abrogated osteoblast gene expression induced by either LV‐FGF18 or rhFGF18, indicating that FGF18 enhances osteoblast differentiation in MSCs via activation of FGFR1 or FGFR2 signaling. Biochemical and pharmacological analyses showed that the induction of phenotypic osteoblast markers by LV‐FGF18 is mediated by activation of ERK1/2‐MAPKs and PI3K signaling in MSCs. These results reveal that FGF18 is an essential autocrine positive regulator of the osteogenic differentiation program in murine MSCs and indicate that osteogenic differentiation induced by FGF18 in MSCs is triggered by FGFR1/FGFR2‐mediated ERK1/2‐MAPKs and PI3K signaling. J. Cell. Physiol. 224: 509–515, 2010. © 2010 Wiley‐Liss, Inc.

[1]  T. Fujita,et al.  Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling , 2004, The Journal of cell biology.

[2]  Renny T. Franceschi,et al.  Critical role of the extracellular signal–regulated kinase–MAPK pathway in osteoblast differentiation and skeletal development , 2007, The Journal of cell biology.

[3]  Martina I Reinhold,et al.  Direct Interactions of Runx2 and Canonical Wnt Signaling Induce FGF18* , 2006, Journal of Biological Chemistry.

[4]  D. Ornitz,et al.  Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. , 2002, Genes & development.

[5]  Su‐Li Cheng,et al.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. , 1994, Endocrinology.

[6]  B. Shenker,et al.  Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. , 1994, Developmental biology.

[7]  C. Scharff,et al.  Gene Expression Changes in the Course of Neural Progenitor Cell Differentiation , 2022 .

[8]  S. K. Zaidi,et al.  Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. , 2004, Critical reviews in eukaryotic gene expression.

[9]  M. Buschmann,et al.  Fibroblast Growth Factor (FGF) 18 Signals through FGF Receptor 3 to Promote Chondrogenesis* , 2005, Journal of Biological Chemistry.

[10]  F. Lokiec,et al.  Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. , 1998, Bone.

[11]  V. P. Eswarakumar,et al.  Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.

[12]  P. Marie,et al.  Transcription factors controlling osteoblastogenesis. , 2008, Archives of biochemistry and biophysics.

[13]  H. S. Kang,et al.  Krüppel‐Like Zinc Finger Protein Glis3 Promotes Osteoblast Differentiation by Regulating FGF18 Expression , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  A. Baldini,et al.  Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia , 1997, Nature Genetics.

[15]  K. Moriyama,et al.  Fibroblast Growth Factor Receptor 2 Promotes Osteogenic Differentiation in Mesenchymal Cells via ERK1/2 and Protein Kinase C Signaling* , 2009, Journal of Biological Chemistry.

[16]  T. Fujita,et al.  Runx 2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI 3 K-Akt signaling , 2004 .

[17]  O. Fromigué,et al.  Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. , 1997, Cytokine.

[18]  J. Stock,et al.  Targeted Disruption of the Osteoblast/Osteocyte Factor 45 Gene (OF45) Results in Increased Bone Formation and Bone Mass* , 2003, The Journal of Biological Chemistry.

[19]  D. Ambrosetti,et al.  Mechanisms underlying differential responses to FGF signaling. , 2005, Cytokine & growth factor reviews.

[20]  A. Caplan,et al.  A Quadripotential Mesenchymal Progenitor Cell Isolated from the Marrow of an Adult Mouse , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  N. Itoh,et al.  FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. , 2002, Genes & development.

[22]  G. Pelled,et al.  Applications of gene therapy and adult stem cells in bone bioengineering. , 2006, Regenerative medicine.

[23]  Janet L Stein,et al.  Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression* , 2005, Journal of Biological Chemistry.

[24]  O. Fromigué,et al.  Osteogenic differentiation of human marrow-derived mesenchymal stem cells. , 2006, Regenerative medicine.

[25]  R. Schüle,et al.  FHL2 mediates dexamethasone‐induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β‐catenin signaling‐dependent Runx2 expression , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  D. Heath,et al.  Expression Profiling and Functional Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells , 2004, Stem cells.

[27]  D. Prockop,et al.  How Wnt Signaling Affects Bone Repair by Mesenchymal Stem Cells from the Bone Marrow , 2005, Annals of the New York Academy of Sciences.

[28]  R. Behringer,et al.  Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. , 2006, Genes & development.

[29]  B. L. Riggs,et al.  Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein‐2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte Maturation , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[31]  P. Marie.  Fibroblast growth factor signaling controlling osteoblast differentiation. , 2003, Gene.

[32]  O. Fromigué,et al.  Distinct osteoblastic differentiation potential of murine fetal liver and bone marrow stroma‐derived mesenchymal stem cells , 2008, Journal of cellular biochemistry.

[33]  I. Martin,et al.  Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. , 1997, Endocrinology.

[34]  Mara Riminucci,et al.  Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications , 2001, Stem cells.

[35]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[36]  Rocky S Tuan,et al.  Canonical and non‐canonical wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells , 2007, Journal of cellular physiology.

[37]  M. Kassem.  Stem Cells , 2006, Annals of the New York Academy of Sciences.

[38]  P. Marie,et al.  FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. , 2002, Genes & development.

[39]  Liping Xiao,et al.  Stat1 Controls Postnatal Bone Formation by Regulating Fibroblast Growth Factor Signaling in Osteoblasts* , 2004, Journal of Biological Chemistry.

[40]  V. Rosen,et al.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.

[41]  M. Pittenger,et al.  Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein Kinase* , 2000, The Journal of Biological Chemistry.